- Featured Product
- KD/KO Validated
c-MYC Monoklonaler Antikörper
c-MYC Monoklonal Antikörper für FC, IHC, WB, ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IP, IHC, FC, CoIP, ChIP, ELISA
Konjugation
Unkonjugiert
CloneNo.
3D9C12
Kat-Nr. : 67447-1-Ig
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | MDA-MB-231-Zellen, 4T1-Zellen, HL-60-Zellen, HT-29-Zellen, K-562-Zellen, NIH/3T3-Zellen, PC-3-Zellen, Raji-Zellen, RAW 264.7-Zellen |
Erfolgreiche Detektion in IHC | humanes Kolonkarzinomgewebe, humanes Tonsillitisgewebe, humanes Zervixkarzinomgewebe, Maushirngewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in FC | K-562-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunhistochemie (IHC) | IHC : 1:500-1:2000 |
Durchflusszytometrie (FC) | FC : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 3 publications below |
WB | See 58 publications below |
IHC | See 12 publications below |
IP | See 5 publications below |
CoIP | See 5 publications below |
ChIP | See 1 publications below |
Produktinformation
67447-1-Ig bindet in WB, IP, IHC, FC, CoIP, ChIP, ELISA c-MYC und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Maus / IgG1 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | c-MYC fusion protein Ag17519 |
Vollständiger Name | v-myc myelocytomatosis viral oncogene homolog (avian) |
Berechnetes Molekulargewicht | 49 kDa |
Beobachtetes Molekulargewicht | 55-60 kDa |
GenBank-Zugangsnummer | BC000141 |
Gene symbol | MYC |
Gene ID (NCBI) | 4609 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MYC contains one basic helix-loop-helix (bHLH) domain. This protein is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. It seems to activate the transcription of growth-related genes. It binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma.
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for c-MYC antibody 67447-1-Ig | Protokoll herunterladen |
IHC protocol for c-MYC antibody 67447-1-Ig | Protokoll herunterladen |
FC protocol for c-MYC antibody 67447-1-Ig | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Gastroenterology Nucleolar HEATR1 upregulated by mTORC1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis | ||
Drug Resist Updat Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression
| ||
Nat Commun ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer | ||
Mol Cell The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis. | ||
Acta Pharm Sin B Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors. | ||
Cell Death Differ E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis. |
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Tanis (Verified Customer) (03-15-2022) | Antibody was strong, clean, and specific in our application.
|